文献速递慢阻肺

慢阻肺急性加重后非致死性心血管事件的时间风险:一项基于人群的研究

Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study.
PubMed 文献 · Am J Respir Crit Care Med · 2024-01-01

该研究基于英国初级保健数据库纳入2014至2020年慢阻肺患者213466例,其中146448例(68.6%)发生过急性加重,共记录40773例心血管事件。急性加重后1-14天心血管事件风险立即升高(aHR 3.19,95%CI 2.71-3.76),重度加重后1-14天aHR达14.5(95%CI 12.2-17.3),中度加重后14-30天aHR为1.94(95%CI 1.63-2.31),且风险升高持续超过一年。

要点

  • 任何急性加重后1-14天心血管风险显著升高,需警惕急性冠脉综合征、心律失常与心衰。
  • 重度加重后两周内风险最高(aHR 14.5),中度加重风险高峰稍晚(14-30天,aHR 1.94)。
  • 无论加重严重程度,心血管相对风险升高可持续超过一年(aHR 1.84)。

核心结论

  • 中度慢阻肺急性加重后心血管事件发生略晚于重度加重。
  • 无论加重严重程度,升高的心血管相对风险持续超过一年。
  • 急性加重后立即阶段是临床干预和优化治疗以预防心血管事件的关键窗口。

研究设计与样本

  • 基于英国临床实践研究数据链Aurum初级保健数据库的人群研究,纳入2014至2020年英格兰慢阻肺患者。
  • 共纳入213466例患者,146448例(68.6%)有急性加重,119124例(55.8%)为中度加重,27324例(12.8%)为重度加重。
  • 采用调整Cox回归模型估计平均及按时间分层的调整风险比(aHR)。
  • 心血管结局取自链接的住院数据,包括复合及个体事件(急性冠脉综合征、心律失常、心力衰竭、缺血性卒中、肺动脉高压)。

主要发现

  • 共记录40773例心血管事件。
  • 任何急性加重后1-14天心血管相对率立即升高(aHR 3.19,95%CI 2.71-3.76),随后逐步下降但仍维持升高,一年后为aHR 1.84(95%CI 1.78-1.91)。
  • 重度加重后1-14天风险比最高(aHR 14.5,95%CI 12.2-17.3),中度加重后14-30天最高(aHR 1.94,95%CI 1.63-2.31)。
  • 重度加重后两周内效应最大的心血管结局为心律失常(aHR 12.7,95%CI 10.3-15.7)和心力衰竭(aHR 8.31,95%CI 6.79-10.2)。

临床怎么用

  • 慢阻肺急性加重后应关注心血管事件风险,尤其是重度加重后两周内。
  • 中度加重后14-30天仍需警惕心血管事件。
  • 急性加重后一年内持续评估并优化心血管危险因素管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Cardiovascular events after chronic obstructive pulmonary disease (COPD) exacerbations are recognized. Studies to date have been post hoc analyses of trials, did not differentiate exacerbation severity, included death in the cardiovascular outcome, or had insufficient power to explore individual outcomes temporally.Objectives: We explore temporal relationships between moderate and severe exacerbations and incident, nonfatal hospitalized cardiovascular events in a primary care-derived COPD cohort.Methods: We included people with COPD in England from 2014 to 2020, from the Clinical Practice Research Datalink Aurum primary care database. The index date was the date of first COPD exacerbation or, for those without exacerbations, date upon eligibility. We determined composite and individual cardiovascular events (acute coronary syndrome, arrhythmia, heart failure, ischemic stroke, and pulmonary hypertension) from linked hospital data. Adjusted Cox regression models were used to estimate average and time-stratified adjusted hazard ratios (aHRs).Measurements and Main Results: Among 213,466 patients, 146,448 (68.6%) had any exacerbation; 119,124 (55.8%) had moderate exacerbations, and 27,324 (12.8%) had severe exacerbations. A total of 40,773 cardiovascular events were recorded. There was an immediate period of cardiovascular relative rate after any exacerbation (1-14 d; aHR, 3.19 [95% confidence interval (CI), 2.71-3.76]), followed by progressively declining yet maintained effects, elevated after one year (aHR, 1.84 [95% CI, 1.78-1.91]). Hazard ratios were highest 1-14 days after severe exacerbations (aHR, 14.5 [95% CI, 12.2-17.3]) but highest 14-30 days after moderate exacerbations (aHR, 1.94 [95% CI, 1.63-2.31]). Cardiovascular outcomes with the greatest two-week effects after a severe exacerbation were arrhythmia (aHR, 12.7 [95% CI, 10.3-15.7]) and heart failure (aHR, 8.31 [95% CI, 6.79-10.2]).Conclusions: Cardiovascular events after moderate COPD exacerbations occur slightly later than after severe exacerbations; heightened relative rates remain beyond one year irrespective of severity. The period immediately after an exacerbation presents a critical opportunity for clinical intervention and treatment optimization to prevent future cardiovascular events.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Graul, Nordon, Rhodes, et al. Temporal Risk of Nonfatal Cardiovascular Events After Chronic Obstructive Pulmonary Disease Exacerbation: A Population-based Study. Am J Respir Crit Care Med. 2024. PMID: 38127850. doi:10.1164/rccm.202307-1122OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。